* MiMedx Group Inc MDXG.OQ MDXG.O is expected to show a
rise
in quarterly revenue when it reports results
* The Marietta Georgia-based company is expected to report
a
15.4% increase in revenue to $78.122 million from $67.69 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for MiMedx Group Inc is
for
earnings of 4 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for MiMedx
Group Inc
is $12, above its last closing price of $6.15.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 -0.02 -0.02 0.00 Beat 100
Mar. 31 2023 -0.08 -0.09 -0.06 Beat 30.8
Dec. 31 2022 -0.04 -0.04 -0.02 Beat 45.5
Sep. 30 2022 -0.07 -0.08 -0.09 Missed -16.1
Jun. -0.05 -0.06 -0.11 Missed -94.1
30 2022
Mar. 31 2022 -0.10 -0.10 -0.11 Missed -10
Dec. 31 2021 -0.02 -0.03 0.01 Beat 130
Sep. 30 2021 -0.08 -0.08 -0.04 Beat 50
This summary was machine generated October 28 at 01:09 GMT. All
figures in US dollars unless otherwise stated